Literature DB >> 8387946

Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma.

K Takahashi1, J Kudo, H Ishibashi, Y Hirata, Y Niho.   

Abstract

We investigated 24 hepatocellular carcinomas in Japan to find loss of heterozygosity with 15 polymorphic DNA markers that detect allelic losses at specific chromosome loci. Loss of heterozygosity on chromosomes 10q, 17p and 22q was detected in 3 of 12 (25%), 9 of 21 (43%) and 5 of 15 (33%) informative cases of hepatocellular carcinoma, respectively. This is the first report of loss of heterozygosity on chromosome 22q in hepatocellular carcinoma; the newly recognized common chromosome loss was considered to exist between D22S9 and D22S10 on 22q11. On the basis of this and other studies, we believe it is likely that such a chromosome loss in hepatocellular carcinoma is a signal for malignant transformation and that loss of unknown genes on chromosomes 10q, 17p and 22q may contribute to tumor progression in hepatocellular carcinoma.

Entities:  

Mesh:

Year:  1993        PMID: 8387946

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  18 in total

1.  Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma.

Authors:  K Ashida; Y Kishimoto; K Nakamoto; K Wada; G Shiota; Y Hirooka; Y Kamisaki; T Itoh; H Kawasaki
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma.

Authors:  Y Kishimoto; G Shiota; K Wada; M Kitano; K Nakamoto; Y Kamisaki; T Suou; T Itoh; H Kawasaki
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 3.  Viruses and hepatocellular carcinoma.

Authors:  S Sherlock
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

4.  Detailed deletion mapping of loss of heterozygosity on 22q13 in sporadic colorectal cancer.

Authors:  Hai-Tao Zheng; Zhi-Hai Peng; Chong-Zhi Zhou; Da-Peng Li; Zhao-Wen Wang; Guo-Qiang Qiu; Lin He
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

5.  Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer.

Authors:  Yina Gao; Jingshu Geng; Xuan Hong; Jiping Qi; Yang Teng; Yang Yang; Di Qu; Gongyan Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

6.  Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma.

Authors:  Chong-Zhi Zhou; Zhi-Hai Peng; Fang Zhang; Guo-Qiang Qiu; Lin He
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

7.  Genomic instability of murine hepatocellular carcinomas with low and high metastatic capacities.

Authors:  Shu-Hui Zhang; Wen-Ming Cong; Jing-Quan Shi; Hong Wei
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

8.  ATF4 loss of heterozygosity is associated with poor overall survival in medullary thyroid carcinoma.

Authors:  Michelle D Williams; Junsheng Ma; Elizabeth G Grubbs; Robert F Gagel; Rozita Bagheri-Yarmand
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

9.  T lymphocytes, CD68-positive cells and vascularisation in thyroid carcinomas.

Authors:  G Herrmann; P M Schumm-Draeger; C Müller; E Atai; B Wenzel; T Fabian; K H Usadel; K Hübner
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

10.  MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma.

Authors:  Zuping Zhang; Hailin Tang; Zeyou Wang; Baoxin Zhang; Wei Liu; Hongmei Lu; Lan Xiao; Xiaoping Liu; Rong Wang; Xiaoling Li; Minghua Wu; Guiyuan Li
Journal:  Mol Cancer       Date:  2011-09-30       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.